ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

Komen Under Pressure: Charity Faces Money Woes, Attacks from Right

October 26, 2012

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

July 27, 1984

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

In Brief: Schilsky Succeeds McIntyre As CALB Chair; UC Irvine Awarded New Cancer Center Grants

November 11, 1994

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988